Medtronic’s Anti-Bacterial Implantable Device Envelope Proves Cost-Effective In Study
A new analysis of the WRAP IT study shows the Tyrx absorbable antibacterial envelope is a cost-effective tool for preventing infections around cardiac implantable electronic devices.
You may also be interested in...
June, July and August brought a number of important new approvals and trial announcements from the major cardiac device companies. Here are some of the highlights you might have missed during the summer.
Start-Up Spotlight: Resonant Link Plans To Electrify Device Industry With Efficient Wireless Charging Technology
The company is commercializing technology developed at Dartmouth and Stanford universities, hoping that its technology will reduce the size and complication rates of implantable devices.
Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.